These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38723370)

  • 1. TM-Score predicts immunotherapy efficacy and improves the performance of the machine learning prognostic model in gastric cancer.
    Xiang K; Zhang M; Yang B; Liu X; Wang Y; Liu H; Song Y; Yuan Y; Zhang L; Wen T; Zhang GW
    Int Immunopharmacol; 2024 Jun; 134():112224. PubMed ID: 38723370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel biomarker associated with EBV infection improves response prediction of immunotherapy in gastric cancer.
    Li X; Xiong F; Hu Z; Tao Q; Yang Y; Qiao X; Peng C; Jiang Y; Han M; Dong K; Hua Y; Zhang W; Xu M; Long W; Xiao Y; Wang D
    J Transl Med; 2024 Jan; 22(1):90. PubMed ID: 38254099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor mutation burden as a biomarker in resected gastric cancer via its association with immune infiltration and hypoxia.
    Wang D; Wang N; Li X; Chen X; Shen B; Zhu D; Zhu L; Xu Y; Yu Y; Shu Y
    Gastric Cancer; 2021 Jul; 24(4):823-834. PubMed ID: 33687617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a CD8+ T cell associated signature for predicting the prognosis and immunological characteristics of gastric cancer by integrating single-cell and bulk RNA-sequencing.
    Li J; Han T; Wang X; Wang Y; Yang R; Yang Q
    Sci Rep; 2024 Feb; 14(1):4524. PubMed ID: 38402299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining single-cell sequencing data to construct a prognostic signature to predict survival, immune microenvironment, and immunotherapy response in gastric cancer patients.
    Hu B; Meng Y; Qu C; Wang BY; Xiu DR
    Front Immunol; 2022; 13():1018413. PubMed ID: 36300104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a Gene Prognostic Model of Gastric Cancer Based on Analysis of Tumor Mutation Burden.
    Ma W; Li W; Xu L; Liu L; Xia Y; Yang L; Da M
    Pathol Oncol Res; 2021; 27():1609852. PubMed ID: 34566519
    [No Abstract]   [Full Text] [Related]  

  • 7. Comprehensive analysis of tumor mutation burden and immune microenvironment in gastric cancer.
    Yu J; Zhang Q; Wang M; Liang S; Huang H; Xie L; Cui C; Yu J
    Biosci Rep; 2021 Feb; 41(2):. PubMed ID: 33492335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated Analysis Construct a Tumor-Associated Macrophage Novel Signature with Promising Implications in Predicting the Prognosis and Immunotherapeutic Response of Gastric Cancer Patients.
    Xin H; Chen Y; Niu H; Li X; Gai X; Cui G
    Dig Dis Sci; 2024 Jun; 69(6):2055-2073. PubMed ID: 38573378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the CD8 + T-cell Related Signature for Predicting the Prognosis of Gastric Cancer Based on Integrated Analysis of Bulk and Single-cell RNA Sequencing Data.
    Zhu ZG; Wang Z; Wu Q; Miao DL; Jin YQ; Chen L
    J Immunother; 2024 Sep; 47(7):239-248. PubMed ID: 38809517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of a gene model related to the prognosis of patients with gastric cancer receiving immunotherapy and exploration of COX7A1 gene function.
    Wang SY; Wang YX; Shen A; Yang XQ; Liang CC; Huang RJ; Jian R; An N; Xiao YL; Wang LS; Zhao Y; Lin C; Wang CP; Yuan ZP; Yuan SQ
    Eur J Med Res; 2024 Mar; 29(1):180. PubMed ID: 38494472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and predictive biomarkers of immunotherapy in Epstein-Barr virus-associated gastric cancer.
    Bai Y; Xie T; Wang Z; Tong S; Zhao X; Zhao F; Cai J; Wei X; Peng Z; Shen L
    J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35241494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Immune Subtypes and Landscape of Gastric Cancer and to Predict Based on the Whole-Slide Images Using Deep Learning.
    Chen Y; Sun Z; Chen W; Liu C; Chai R; Ding J; Liu W; Feng X; Zhou J; Shen X; Huang S; Xu Z
    Front Immunol; 2021; 12():685992. PubMed ID: 34262565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune activity score to assess the prognosis, immunotherapy and chemotherapy response in gastric cancer and experimental validation.
    Wu X; Zhou F; Cheng B; Tong G; Chen M; He L; Li Z; Yu S; Wang S; Lin L
    PeerJ; 2023; 11():e16317. PubMed ID: 38025711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytolytic activity score as a biomarker for antitumor immunity and clinical outcome in patients with gastric cancer.
    Hu Q; Nonaka K; Wakiyama H; Miyashita Y; Fujimoto Y; Jogo T; Hokonohara K; Nakanishi R; Hisamatsu Y; Ando K; Kimura Y; Masuda T; Oki E; Mimori K; Oda Y; Mori M
    Cancer Med; 2021 May; 10(9):3129-3138. PubMed ID: 33769705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and verification of a manganese metabolism- and immune-related genes signature for prediction of prognosis and immune landscape in gastric cancer.
    Han X; Leng C; Zhao S; Wang S; Chen S; Wang S; Zhang M; Li X; Lu Y; Wang B; Qi W
    Front Immunol; 2024; 15():1377472. PubMed ID: 38807601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis reveals that P4HA3 is a prognostic and diagnostic gastric cancer biomarker that can predict immunotherapy efficacy.
    Yu Y; Luo K; Liu M; Chen L; Gao X; Zhang L; Li X; Zhang H
    Sci Rep; 2024 Oct; 14(1):22959. PubMed ID: 39362976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GGT5: a potential immunotherapy response inhibitor in gastric cancer by modulating GSH metabolism and sustaining memory CD8+ T cell infiltration.
    Zhao W; Liang Z; Yao Y; Ge Y; An G; Duan L; Yao J
    Cancer Immunol Immunother; 2024 May; 73(7):131. PubMed ID: 38748299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a Tumor Microenvironment-relevant Gene set-based Prognostic Signature and Related Therapy Targets in Gastric Cancer.
    Cai WY; Dong ZN; Fu XT; Lin LY; Wang L; Ye GD; Luo QC; Chen YC
    Theranostics; 2020; 10(19):8633-8647. PubMed ID: 32754268
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of N7-methylguanosine related subtypes and construction of prognostic model in gastric cancer.
    Li X; Dong H; Chen L; Wang Y; Hao Z; Zhang Y; Jiao Y; Zhao Z; Peng X; Zhan X
    Front Immunol; 2022; 13():984149. PubMed ID: 36300121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2.
    Xu S; Chen X; Fang J; Chu H; Fang S; Zeng L; Ma H; Zhang T; Chen Y; Wang T; Zhang X; Shen T; Zheng Y; Xu D; Lu Z; Pan Y; Liu Y
    Front Immunol; 2023; 14():1155182. PubMed ID: 37275857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.